Position in BMY
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,826,994,388
+$1,205,317,454 QoQ
Shares Held
31,707,643
+209.3% QoQ
Ownership
1.55%
of shares outstanding
% of Portfolio
0.19%
of 13F equity value
Holder Rank
#10
of 2,506 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 96%
Shared 0%
None 4%
Common Shares in BMY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026PRICE T ROWE ASSOCIATES INC /MD/ holds $40,270,584,407 across 16 Drug Manufacturers - General names. BMY ranks #7 (4.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
13,911,839 | $16,686,278,442 | |
| 2 | JNJ |
Johnson & Johnson
|
22,996,878 | $5,840,517,105 | |
| 3 | GILD |
Gilead Sciences, Inc.
|
29,996,694 | $3,789,782,319 | |
| 4 | ABBV |
AbbVie Inc.
|
14,749,069 | $3,711,455,722 | |
| 5 | AZN |
Astrazeneca PLC
|
16,616,629 | $3,150,845,190 | |
| 6 | MRK |
Merck & Co., Inc.
|
18,518,796 | $2,379,665,285 | |
| 7 | BMY |
Bristol Myers Squibb Co
This page
|
31,707,643 | $1,826,994,388 | |
| 8 | AMGN |
Amgen Inc
|
3,956,992 | $1,432,905,943 |
All Filings in BMY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,826,994,388 | 31,707,643 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $621,676,934 | 10,250,238 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $371,078,880 | 6,879,475 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $348,131,274 | 7,719,097 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $336,695,637 | 7,273,615 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $353,094,041 | 5,789,376 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $425,778,645 | 7,527,911 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $1,047,206,371 | 20,239,783 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $635,424,406 | 15,300,371 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $680,468,440 | 12,547,823 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $363,585,533 | 7,086,056 | Shares | Sole | 2024-02-16 | |
| 2023-09-30 | $387,955,204 | 6,684,273 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $391,996,936 | 6,129,741 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $485,711,934 | 7,007,819 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $532,246,814 | 7,397,454 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $432,617,767 | 6,085,494 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $1,123,200,771 | 14,587,023 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $1,154,112,662 | 15,803,268 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $209,371,549 | 3,358,004 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $230,715,604 | 3,899,199 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $238,783,875 | 3,573,539 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $229,126,799 | 3,629,444 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $244,094,190 | 3,935,099 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $414,628,859 | 6,877,241 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $508,235,742 | 8,643,465 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $540,390,381 | 9,694,840 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||